1. Signaling Pathways
  2. Metabolic Enzyme/Protease
  3. MMP
  4. MMP Antagonist

MMP Antagonist

MMP Antagonist (1):

Cat. No. Product Name Effect Purity
  • HY-P10775
    BT1769
    Antagonist
    BT1769 is a MT1-MMP-targeted (KD = 3.35 nM) Bicycle toxin conjugate. BT1769 can be used in the study for osteosarcoma. BT1769 consists of a novel bicyclic targeting peptide that selectively binds MT1-MMP; a cytotoxin MMAE; and an enzymatically cleavable dipeptide linker.